Reneo Pharmaceuticals (RPHM) Q3 2023 Earnings

13NovConfirmed
Nov 22
Q4 2022
Q2 2023
Q3 2023
-0.65
-0.61
-0.56
-0.52

Details

Expected EPS
-0.57
Actual EPS
-0.57
Surprise EPS
0
Surprise Percent
+0%

Description

Reneo Pharmaceuticals (RPHM) has reported earnings of -0.57 per share for Q3 2023.

0 Comments

Share your thoughts